Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 818 results for "pfizer drugmaker pfizer"

Pfizer to help investors with dividend, buybacks

SHORT HILLS, N.J. -- Pfizer Inc. CEO Ian Read says the drugmaker will keep working to boost shareholder value, with continuing stock buybacks and higher dividends. At Pfizer's annual meeting in Short Hills, N.J., the Viagra maker said it will pay a ... Miami Herald, 1 hour ago

28 images for pfizer drugmaker pfizer

BusinessWeek, 1 day ago
Jutia Group, 1 week ago
Bloomberg, 1 day ago
Times of India, 2 weeks ago
Times Live South Africa, 2 weeks ago
Business News Network, 1 month ago
Jutia Group, 2 months ago
Rediff.com, 2 months ago
Proactive Investors USA, 2 months ago
WWMT, 2 months ago
BusinessWeek

Is This Struggling Drugmaker Worth $100 Billion?

The pharmaceutical world got a shock this week from reports that Pfizer ( NYSE: PFE ) had engaged in informal talks with Big Pharma rival AstraZeneca ( NYSE: AZN ) about a possible $100 billion acquisition. AstraZeneca reportedly expressed no ...
 Motley Fool8 hours ago Pfizer Agrees to Pay $190 Million to Settle Neurontin Case (1)  BusinessWeek2 days ago Pfizer Said to Have Held Talks to Acquire AstraZeneca  Bloomberg3 days ago Pfizer in talks to buy AstraZeneca  The Japan News3 days ago
[x]  
Financial Express

New kind of trial aims to speed cancer drug development

* AstraZeneca, Pfizer, UK charity link in multi-drug trial * Scope to test up to 14 drugs within same clinical study * Approach marks radical break with traditional trial design * Advances in genetic medicine allows remodelled trials * Could ...
 CNBC1 week ago AstraZeneca and Pfizer Collaborate on a New Oncology Trial Design  American Journal of Managed Care1 week ago One Of A Kind Trial To Test 14 AstraZeneca PLC, Pfizer Inc. Drugs At The Same Time  BioSpace1 week ago New kind of trial offers hope of cancer cure  Financial Express1 week ago
[x]  
Proactive Investors.co.uk

AstraZeneca boss defends strategy as analysts say sales could fetch $15bn

bows of bigger US rival Pfizer, a potential suitor, as he insisted that the British drugmaker's strategy was working and highlighted progress with new cancer drugs. He also indicated
 Big News Network1 hour ago 4 AstraZeneca reportedly rejects £60bn approach from Pfizer  Irish Times1 day ago AstraZeneca quiet on Pfizer bid  Proactive Investors.co.uk14 hours ago Pfizer may return for AstraZeneca after initial approach  Irish Times2 days ago
[x]  
Jutia Group

Pfizer settles US patent litigation with Actavis over generic Celebrex

Pfizer settled patent litigation allowing Actavis to launch a generic version of Celebrex (celecoxib) in the US beginning in December 2014, or earlier under certain circumstances, Actavis reported Thursday. The company suggested that it may be the ...
 FirstWord Pharma2 hours ago Pfizer concedes Celebrex to Actavis, Teva after 2015 patent strike-down  FiercePharma6 hours ago UPDATE 2-Teva settles patent suit with Pfizer over Celebrex  Reuters1 week ago Teva, Pfizer settle patent lawsuit over painkiller Celebrex  CNBC1 week ago
[x]  
Invezz

Pfizer Approached AstraZeneca in $101 Billion Bid, Times Says

Advertisement April 20 (Bloomberg) -- Pfizer Inc. approached AstraZeneca Plc about acquiring the U.K. drugmaker in a deal that would value the company at more than 60 billion pounds ($101 billion), according to a media report. The talks were ...
 GARP14 hours ago AstraZeneca share price leaps after reports of Pfizer approach  Invezz2 days ago Pfizer Made $101 Billion Bid for AstraZeneca, Times Says  Bloomberg4 days ago
Motley Fool

Pfizer's Missed Megadeal Sparks the Dow's Rise

The market opened the week on an upbeat note, with the major stock indices all modestly on the upswing. The Dow Jones Industrial Average ( DJINDICES: ^DJI ) was up more than 45 points as of 2:35 p.m. EDT. Big Pharma's Pfizer ( NYSE: PFE ) has ...
 Motley Fool3 days ago Dow Rises Slightly on Pfizer-AstraZeneca Reports; Disney Gives up Ground  Motley Fool3 days ago Dow Climbs As Pharma Stocks Jump, but Will Drug M&A Hurt UnitedHealth?  Motley Fool2 days ago Dow Drops Despite Intel Upgrade; Pfizer, Visa Drag  Motley Fool2 weeks ago

Pfizer and AstraZeneca Ripe for Deal Alone or Together: Real M

(For a Real M&A column news alert: SALT REALMNA GO.) April 22 (Bloomberg) -- Large deals make sense for Pfizer Inc. and AstraZeneca Plc, even if not with each other. While the talks between Pfizer, the world's biggest drugmaker, and $87 billion ...
 Washington Post2 days ago Pfizer, AstraZeneca Are Ripe for Pharma Deal: Real M  Bloomberg2 days ago
[x]  
Finance 24

Novartis shake-up, Pfizer-AstraZeneca report lifts pharma stocks

LONDON, April 22 (Reuters) - Shares in European drugmakers received a shot in the arm on Tuesday amid a flurry of activity, with Novartis striking a multi-billion dollar deal with GlaxoSmithKline and reports U.S. giant Pfizer had approached ...
 CNBC2 days ago Shares in EU drugmakers jump  Finance 242 days ago Novartis shake-up Pfizer-AstraZeneca report lifts pharma stocks  Big News Network2 days ago
[x]  

Stocks Rise In Weak Volume; Pfizer Paces Drugmakers

Stocks rose in slow volume Monday, with the S&P 500 rising for a fifth straight session, ahead of key earnings reports. The Nasdaq advanced 0.6%, while the S&P 500 rose 0.3% and the Dow Jones industrials edged up 0.2% each. Volume was sharply ...
 Investor's Business Daily3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less